CS logo
small CS logo
I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze

Praha 2, Czechia

About I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze


During the past decade, I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze" #1 collaborator was "AbbVie" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze


According to Clinical.Site data, the most researched conditions in "I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze" are "Lymphoma" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze" in a lesser frequency.

Clinical Trials Intervention Types at I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze


Most popular intervention types in "I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Nivolumab" (2 trials), "Dexamethasone" (1 trials), "Elotuzumab" (1 trials) and "Pomalidomide" (1 trials). Other intervention names were less common.

Clinical Trials Genders at I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze


The vast majority of trials in "I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze" are 2 trials for "All" genders.

Clinical Trials Status at I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze


Currently, there are NaN active trials in "I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".